Stanford University
Showing 7,001-7,050 of 34,489 Results
-
Stanley Deresinski
Clinical Professor, Medicine - Infectious Diseases
BioDr. Deresinski received his medical degree from the University of Illinois College of Medicine and received training in Internal Medicine there and at Stanford, where he also completed a fellowship in Infectious Diseases. For 3 decades, he maintained a private practice in Infectious Disease, HIV, and Travel Medicine and was Hospital Epidemiologist at Sequoia Hospital where he also served as President of the Medical Staff for 2 years. He was also Associate Chief of the Division of Infectious Diseases and for 14 years was Director of the AIDS Program at the Santa Valley Medical Center, a Stanford-affiliated public teaching hospital. During that time he won several teaching awards at Stanford. In 1987, he founded the AIDS Community Research Consortium, serving as its Medical Director and Chairman of the Board for almost 2 decades. He was also Site Principal Investigator for the Stanford ACTU and the California Collaborative Treatment Group and has worked on AIDS education in Kampala, Uganda. Dr. Deresinski is currently Clinical Professor of Medicine in the Division of Infectious Diseases and Geographic Medicine at Stanford and is Medical Director of the Stanford Antimicrobial Stewardship Program and Chair of the Pharmacy and Therapeutics Committee and of the Specialty Drugs Subcommittee. He has special interests in antimicrobial resistance, optimal antimicrobial use, fungal infections, and infections in immunocomopromised hosts.
Dr. Deresinski has published more than 100 peer-reviewed papers as well as number of book chapters. He is a Section Editor of Clinical Infectious Diseases and is a past Chair of the Infectious Diseases Society of America (IDSA) Standards and Practice Guidelines Committee as well as member of the IDSA Board of Directors. He is a member of the HIVMA, in addition to a number of other societies including SHEA and is a Fellow in the American College of Physicians as well as IDSA. He is a past winner of the IDSA Watanakunokorn Clinician of the YearAward. -
Laura T Derry
Clinical Assistant Professor, Medicine
BioDr. Laura (Trollinger) Derry is a Clinical Assistant Professor of Medicine and hospitalist specializing in the care of complex medical and surgical patients. She completed her medical training at the University of North Carolina (UNC) School of Medicine and Internal Medicine residency at the University of California, San Francisco (UCSF), where she was part of the Health Systems Leadership (HSL) Pathway. She also holds an MBA from Duke University’s Fuqua School of Business, specializing in health sector management and leadership.
Dr. Derry serves as the Associate Chief Quality Officer (ACQO) for Inpatient Care at Stanford Health Care. She is actively involved in quality improvement initiatives within the Division of Hospital Medicine and a member of the Orthopedics Quality Council. She is a graduate of Stanford Medicine's Realizing Improvement through Team Empowerment (RITE) program and has served as a Cohort Director. She also serves as the Co-Director of Hospital Medicine Labs for Clinical Operations whose mission is to transform inpatient care delivery through the rigorous design, pilot-testing, and scaling of operational innovations. She is a faculty advisor and instructor for the Stanford Healthcare Consulting Group (SHCG), mentoring students in healthcare strategy, operations, and quality improvement.
Beyond clinical care, Dr. Derry conducts research at the intersection of artificial intelligence and medicine, exploring how large language models and machine learning can enhance physician decision-making, disease diagnosis, and healthcare delivery. She received one of the inaugural SMART-HM grants through the Stanford Division of Hospital Medicine to support her research and has received funding from the American Heart Association (AHA).
Before her medical career, Dr. Derry worked as a strategy consultant, applying data-driven insights to optimize clinical operations and care delivery. Her expertise in clinical operations, quality improvement, and digital strategy continues to shape her work at Stanford and beyond. -
Atman Desai, MD
Clinical Professor, Neurosurgery
Current Research and Scholarly InterestsThe Stanford Spine Artificial Intelligence Laboratory develops data-driven technologies to improve diagnosis, surgical planning, and outcomes in spine care. Our research spans predictive modeling, computational imaging, spinal oncology, digital surgery, and real-world functional assessment using wearables. By integrating clinical, imaging, and functional data at scale, we aim to deliver clinically meaningful, patient-centered innovations for complex spinal disease.
-
Dimpi Desai, MD
Clinical Associate Professor, Medicine - Endocrinology, Gerontology, & Metabolism
BioDr. Dimpi Desai, MD is a Clinical Associate Professor at Stanford University. She did her residency in Internal Medicine from Jacobi Medical Center/Albert Einstein College of Medicine in New York and completed her fellowship in Endocrinology at the University of Pennsylvania.
Her main clinical focus includes diabetes and obesity and preventing their long-term complications. She strongly believes in patient education and involving them in the medical decision-making process. In addition to being a clinician, she is committed to and involved in the medical education of trainees at all levels including medical students, residents and fellows. She is triple board certified in internal medicine, endocrinology and Obesity. She is involved in several national endocrinology and obesity societies in leadership roles and currently serves as a member on the guideline panel for Endocrine Society's pharmacological management of Obesity. -
Gauri Desai
Postdoctoral Scholar, Bioengineering
BioDr. Gauri Desai is a Postdoctoral Research Associate with the Female Athlete Science and Translational Research Program (FASTR). She is a biomechanist, with a research focus on female-specific biomechanical risk factors for sport-related injuries. She integrates biomechanics principles with physiology to provide an all-round perspective on improving performance and mitigating injury risk in female athletes. Dr. Desai's research complements human subject experiments with insights from computer modeling and simulation, to answer research questions that are challenging to address via human subject research studies alone. Beyond research, she is an active contributor to the sports science community through mentorship and advocacy for women in sport.
-
Kaniksha Desai
Clinical Professor, Medicine - Endocrinology, Gerontology, & Metabolism
BioDr. Kaniksha Desai is a board-certified endocrinologist and clinical professor at Stanford University. She completed her endocrinology fellowship at the Mayo Clinic, with an emphasis on the management of patients with thyroid cancer. Dr. Desai’s clinical practice focuses on the management of patients with thyroid nodules and thyroid cancer. She also maintains board certification in neck ultrasonography.
-
Manisha Desai (She/Her/Hers)
Kim and Ping Li Professor, Professor (Research) of Medicine (Computational Medicine - QSU), of Biomedical Data Science and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsDr. Desai is the Director of the Quantitative Sciences Unit. She is interested in the application of biostatistical methods to all areas of medicine including oncology, nephrology, and endocrinology. She works on methods for the analysis of epidemiologic studies, clinical trials, and studies with missing observations.
-
Priyamvada(Priya) Desai
Rsch Technical Mgr 1, Technology & Digital Solutions
Current Role at StanfordManager, Biomedical Informatics R &D
-
Tushar Desai
Professor of Medicine (Pulmonary, Allergy and Critical Care Medicine)
Current Research and Scholarly InterestsBasic and translational research in lung stem cell biology, cancer, pulmonary fibrosis, COPD, and acute lung injury/ARDS. Upper airway stem cell CRISPR gene correction followed by autologous stem cell transplantation to treat Cystic fibrosis. Using lung organoids and precision cut lung slice cultures of mouse and human lungs to study molecular regulation of lung stem cells. Using transgenic mice to visualize Wnt protein transmission from niche cell to stem cell in vivo.
-
Gaelle Desbordes
Sponsored By Stanford University:, Radiology
BioI am a radiologic data systems engineer at Stanford Medicine Children's Health, helping develop and implement data systems for radiologists with the aim to improve diagnostic accuracy and clinical outcomes.
My previous role was as a senior research engineer at Stanford School of Medicine – Radiology, where I was applying deep learning techniques to enhance the detection and classification of various cancer types in medical images.
I was initially trained as an engineer and research scientist – with an MS in Computer Science, PhD in Cognitive and Neural Systems, and postdoctoral training in computational neuroscience and human brain imaging. More recently, I completed a Professional Certificate in Data Engineering and additional training in machine learning and AI.
Over the course of my career, I have designed, built, and coded computational methods for data analysis, collected and analyzed a range of scientific and clinical data, and effectively communicated research findings to diverse audiences. -
Catherine Descanzo
Sr. Assistant Head, Access Services (Circulation), University Libraries
BioI have oversight of the daytime and evening circulation, course reserves, and the student staffing programs in Access Services at Cecil H. Green Library. I also am currently leading the Circulation Subgroup as part of Stanford Libraries' migration to the new open source integrated library system called FOLIO.
-
John DeSilva
Systems & Network Manager, Electrical Engineering
Current Role at StanfordSystems & Network Manager, David Packard Electrical Engineering Building
-
Joseph M. DeSimone
Sanjiv Sam Gambhir Professor of Translational Medicine, Professor of Chemical Engineering and, by courtesy, of Chemistry, of Materials Science and Engineering, and of Operations, Information and Technology at the Graduate School of Business
BioJoseph M. DeSimone is the Sanjiv Sam Gambhir Professor of Translational Medicine and Chemical Engineering at Stanford University. He holds appointments in the Departments of Radiology and Chemical Engineering with courtesy appointments in the Department of Chemistry and in Stanford’s Graduate School of Business.
The DeSimone laboratory's research efforts are focused on developing innovative, interdisciplinary solutions to complex problems centered around advanced polymer 3D fabrication methods. In Chemical Engineering and Materials Science, the lab is pursuing new capabilities in digital 3D printing, as well as the synthesis of new polymers for use in advanced additive technologies. In Translational Medicine, research is focused on exploiting 3D digital fabrication tools to engineer new vaccine platforms, enhanced drug delivery approaches, and improved medical devices for numerous conditions, with a current major focus in pediatrics. Complementing these research areas, the DeSimone group has a third focus in Entrepreneurship, Digital Transformation, and Manufacturing.
Before joining Stanford in 2020, DeSimone was a professor of chemistry at the University of North Carolina at Chapel Hill and of chemical engineering at North Carolina State University. He is also Co-founder, Board Chair, and former CEO (2014 - 2019) of the additive manufacturing company, Carbon. DeSimone is responsible for numerous breakthroughs in his career in areas including green chemistry, medical devices, nanomedicine, and 3D printing. He has published over 350 scientific articles and is a named inventor on over 200 issued patents. Additionally, he has mentored 80 students through Ph.D. completion in his career, half of whom are women and members of underrepresented groups in STEM.
In 2016 DeSimone was recognized by President Barack Obama with the National Medal of Technology and Innovation, the highest U.S. honor for achievement and leadership in advancing technological progress. He has received numerous other major awards in his career, including the U.S. Presidential Green Chemistry Challenge Award (1997); the American Chemical Society Award for Creative Invention (2005); the Lemelson-MIT Prize (2008); the NIH Director’s Pioneer Award (2009); the AAAS Mentor Award (2010); the Heinz Award for Technology, the Economy and Employment (2017); the Wilhelm Exner Medal (2019); the EY Entrepreneur of the Year Award (2019 U.S. Overall National Winner); and the Harvey Prize in Science and Technology (2020). He is one of only 25 individuals elected to all three branches of the U.S. National Academies (Sciences, Medicine, Engineering). DeSimone received his B.S. in Chemistry in 1986 from Ursinus College and his Ph.D. in Chemistry in 1990 from Virginia Tech.
